Alset Inc. (NASDAQ:AEI – Get Free Report) saw a large drop in short interest in November. As of November 15th, there was short interest totalling 1,400 shares, a drop of 89.2% from the October 31st total of 13,000 shares. Based on an average daily trading volume, of 41,500 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.1% of the shares of the company are short sold.
Alset Stock Up 12.0 %
Shares of NASDAQ:AEI opened at $1.21 on Thursday. The stock has a market capitalization of $11.18 million, a PE ratio of -0.28 and a beta of 1.26. The firm’s 50 day moving average price is $1.40 and its 200-day moving average price is $1.20. Alset has a twelve month low of $0.46 and a twelve month high of $2.05.
Insider Buying and Selling
In related news, CEO Heng Fai Ambrose Chan bought 6,034,537 shares of the business’s stock in a transaction on Tuesday, September 24th. The stock was acquired at an average price of $0.63 per share, with a total value of $3,801,758.31. Following the transaction, the chief executive officer now owns 19,264,692 shares in the company, valued at approximately $12,136,755.96. This trade represents a 45.61 % increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. 66.70% of the stock is owned by corporate insiders.
About Alset
Alset Inc engages in the real estate development, financial services, digital transformation technologies, biohealth activities, and consumer products businesses in the United States, Singapore, Hong Kong, Australia, and South Korea. It operates through four segments: Real Estate, Digital Transformation Technology, Biohealth, and Other Business Activities segments.
Featured Stories
- Five stocks we like better than Alset
- How to Use Stock Screeners to Find Stocks
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Alset Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alset and related companies with MarketBeat.com's FREE daily email newsletter.